REFERENCES



REFERENCES: AAC for Multiple Sclerosis, Parkinson’s disease, & Huntington’s disease

Compiled by Kathryn M. Yorkston & David R. Beukelman

From a chapter in the book:

Augmentative Communication Strategies for Adults with Acute and Chronic Medical Conditions

Edited by: David R. Beukelman, Kathryn L. Garrett, Kathryn N. Yorkston

Published by: Paul H. Brookes Publishing Co.

Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh-Sorensen, P. (2001). Risk of dementia in Parkinson's disease. Neurology, 56, 730-736.

Adams, S. G. (1994). Accelerating speech in a case of hypokinetic dysarthria: Descriptions and treatment. In J. A. Till, K. M. Yorkston & D. R. Beukelman (Eds.), Motor speech disorders: Advances in assessment and treatment. (pp. 213-228). Baltimore: Paul H. Brookes Publishing.

Adams, S. G. (1997). Hypokinetic dysarthria in Parkinson's disease. In M. R. McNeil (Ed.), Clinical management of sensorimotor speech disorders (pp. 261-286). New York: Thieme Medical Publishers.

Ahlskog, J. E. (2001). Parkinson's disease: Medical and surgical treatment. Neurologic Clinics, 19(3), 579-605.

Anderson, K. E., Louis, E. D., Stern, Y., & Marder, K. S. (2001). Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. American Journal of Psychiatry, 158(5), 799-801.

Barnes, M. P., Gilhus, N. E., & Wender, M. (2001). Task fore on minimum standards for health care of people with multiple sclerosis: June 1999. European Journal of Neurology, 8, 215-220.

Beukelman, D. R., Kraft, G. H., & Freal, J. (1985). Expressive communication disorders in persons with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 66(10), 675-677.

Beukelman, D. R., & Mirenda, P. (2005). Augmentative and alternative communication: Management of severe communication disorders in children and adults (3rd ed.). Baltimore, MD: Paul H. Brookes Publishing.

Blackwood, H. D., LaPointe, L. L., Holtzapple, P., Pohlman, K., & Graham, L. (1991). Lexical-semantic abilities of individuals with multiple sclerosis and aphasia. In T. Prescott (Ed.), Clinical Aphasiology (Vol. 20, pp. 121-127). Austin, TX: Pro-Ed.

Blake, D. J., & Bodine, C. (2002). An overview of assistive technology for persons with multiple sclerosis. Journal of Rehabilitation Research and Development, 39(2), 299-312.

Boyden, K. M. (2000). The pathophysiology of demyelination and the ionic basis of nerve conduction in multiple sclerosis: An overview. Journal of Neuroscience Nursing, 32, 49-58.

Cariski, D., & Rosenbek, J. (1999). The effectiveness of the Speech Enhancer. Journal of Medical Speech-Language Pathology, 7(4), 315-322.

Coates, C., & Bakheit, A. M. (1997). The prevalence of verbal communication disability in patients with Parkinson's disease. Disability and Rehabilitation, 19(3), 104-107.

Comi, G. (2000). Why treat early multiple sclerosis patients? Current Opinion in Neurology, 13, 235-240.

Cummings, J. L. (1995). Behavioral and psychiatric symptoms associated with Huntington's disease. Advances in Neurology, 65, 179-186.

Darley, F. L., Aronson, A. E., & Brown, J. R. (1975). Motor speech disorders.Philadelphia: W. B. Saunders.

Dawson, S., Kristjanson, L. J., Toye, C. M., & Flett, P. (2004). Living with Huntington's disease: Need for supportive care. Nursing Health Sciences, 6(2), 123-130.

Devere, T. R., Trotter, J. L., & Cross, A. H. (2000). Acute aphasia in multiple sclerosis. Archives of Neurology, 57, 1207-1209.

Downie, A. W., Low, J. M., & Lindsay, D. D. (1981). Speech disorders in parkinsonism: Usefulness of delayed auditory feedback in selected cases. British Journal of Disorders of Communication., 16, 135-139.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55, 1621-1626.

Ebmeier, K. P., Calder, S. A., Crawford, J. R., Stewart, L., Cochrane, R. H., & Besson, J. A. (1991). Dementia in idiopathic Parkinson's disease: Prevalence and relationship with symptoms and signs of parkinsonism. Psychological Medicine, 21, 69-76.

Ehde, D. M., & Bombardier, C. H. (2005). Depression and multiple sclerosis. Physical Medicine & Rehabilitation Clinics of North America, 16, 437-448.

Feys, P., Romberg, A., Ruutiainen, J., Davies-Smith, A., Jone, R., Avizzano, C. A., et al. (2001). Assistive technology to improve PC interaction for people with intention tremor. Journal of Rehabililtation Research and Development, 38, 235-243.

Finlayson, M., Gugliolmello, L., & Liefer, K. (2001). Describing and predicting the possession of assistive devices among persons with multiple sclerosis. American Journal of Occupational Therapy, 55, 545-551.

Ford, H., Trigwell, P., & Johnson, M. (1998). The nature of fatigue in multiple sclerosis. Journal of Pschosomatic Research, 45(1), 33-38.

Garrett, K., & Beukelman. (1992). Augmentative communication in aphasia. In K. M. Yorkston (Ed.), Augmentative communication in the medical setting (pp. 245-338). Tucson: Communication Skill Builders.

Garrett, K. L., & Yorkston, K. M. (1997). Assistive communication technology for elders with cognitive and language disability. In R. Lubinski & J. Higginbotham (Eds.), Communication technologies for the elderly: Vision, hearing, and speech. (pp. 203-234). San Diego: Singular Press.

Gotham, A. M., Brown, R. G., & Marsden, C. D. (1986). Depression in Parkinson's disease: A quantitative and qualitative analysis. Journal of Neurology, Neurosurgery and Psychiatry, 46, 381-389.

Gupta, A., & Bhatia, S. (2000). Depression in Parkinson's disease. Clinical Gerontologist, 22(2), 59-70.

Hakiman, R. (2000). Disclosure of Huntington's disease to family members: The dilemma of knowing but unknowing parties. Genetic Testing, 4(4), 359-364.

Hanson, E. K., Yorkston, K. M., & Beukelman, D. R. (2004). Speech supplementation techniques for dysarthria: A systematic review. Journal of Medical Speech-Language Pathology, 12(2), ix-xxix.

Hanson, W., & Metter, E. (1983). DAF speech rate modification in Parkinson's disease: a report of two cases. In W. Berry (Ed.), Clinical Dysarthria. (pp. 231-254). Austin, TX: ProEd.

Hartelius, L., Runmarker, B., & Andersen, O. (2000). Prevalence and characteristics of dysarthria in a multiple sclerosis incidence cohort: In relation to neurological data. Folia Phoniatrica et Logopaedica, 52, 160-177.

Hartelius, L., & Svensson, P. (1994). Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: A survey. Folia Phoniatrica et Logopaedica, 46, 9-17.

Helm, N. (1979). Management of palilalla with a pacing board. Journal of Speech & Hearing Disorders, 44, 350-353.

Higgins, D. S. (2006). Huntington's disease. Current Treatment Opinion in Neurology, 8(3), 236-244.

Hofmann, N. (1999). Understanding the neuropsychiatric symptoms of Huntington's disease. Journal of Neuroscience Nursing, 31(5), 309-313.

Honsinger, M. J. (1989). Midcourse intervention in multiple sclerosis: An inpatient model. Augmentative and Alternative Communication, 5(1), 71-74.

Huber, S. J., Freidenberg, D. L., Shuttleworth, E. C., Paulson, G. W., & Christy, J. S. (1989). Neuropsychological impairments associated with severity of Parkinson's disease. Journal of Neuropsychiatry Clinical Neurosciences, 1(2), 154-158.

Hunt, V., & Walker, F. O. (1991). Learning to live at risk for Huntington's disease. Journal of Neuroscience Nursing, 23, 179-182.

Jankovic, J. (2005). Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations. Movement Disorders, 20(Suppl 11), S11-S16.

Johnson, C., & Johnson, K. (2005, June). Assistive technology intervention for people with multiple sclerosis. Paper presented at the Consortium of MS Centers, Orlando.

Kennedy, M. R. T. (2000). Topic scenes in conversations with adults with right-hemisphere brain damage. American Journal of Speech-Language Pathology, 9(February), 72-86.

Klasner, E. R., & Yorkston, K. M. (2000). Augmentative communication for Huntington and Parkinson's disease: Planning for Change. In D. R. Beukelman, K. M. Yorkston & J. Reichle (Eds.), Augmentative and alternative communication for adults with acquired neurologic disabilities (pp. 241-279). Baltimore, MD: Paul H. Brookes Publishing.

Klasner, E. R., & Yorkston, K. M. (2001). Linguistic and cognitive supplementation strategies as AAC techniques in Huntington disease: A case report. Augmentative and Alternative Communication, 17(3), 154-160.

Kraft, G. H. (1999). Rehabilitation still the only way to improve function in multiple sclerosis. The Lancet, 354(9195), 2016-2017.

Krupp, L. B., Alvarex, L. A., LaRocca, N. G., & Scheinberg, L. C. (1988). Fatigue in multiple sclerosis. Archives of Neurology, 45, 435-437.

Lacour, A., De Seze, J., Revenco, E., Lebrun, C., Masmoudi, K., Vidry, E., et al. (2004). Acute aphasia in multiple sclerosis: A multicenter study of 22 patients. Neurology, 62, 974-977.

Levin, B. E., Llabre, M. M., Reisman, S., Weiner, W. J., Sanchez-Ramos, J., Singer, C., et al. (1991). Visuspatial impairment in Parkinson's disease. Neurology, 41, 365-369.

Levin, B. E., Tomer, R., & Rey, G. J. (1992). Cognitive impairments in Parkinson's disease. Neurologic Clinics, 10(2), 471-481.

Lipe, H., Schultz, A., & Bird, T. D. (1993). Risk factors for suicide in Huntingtons disease: A retrospective case controlled study. American Journal of Medical Genetics, 48(4), 231-233.

Logemann, J. A., Fisher, H. B., Boshes, B., & Blonsky, E. (1978). Frequency and cooccurence of vocal tract dysfunction in the speech of a large sample of Parkinson patients. Journal of Speech and Hearing Disorders, 43, 47-57.

Lundervold, A. J., & Reinvang, I. (1991). Neuropsychological findings and depressive symptoms in patients with Huntington's disease. Scandinavian Journal of Psychology, 32, 275-283.

Marsden, C. D. (1984). The pathophysiology of movement disorders. Neurologic Clinics, 2, 435-459.

Marttila, R., & Rinne, U. (1991). Progression and survival in Parkinson's disease. Acta Neurologica Scandinavica, 136, 24-28.

Mayeux, R., Stern, Y., Herman, A., Greenbaum, L., & Fahn, S. (1986). Correlates of early disability in Huntington's disease. Annals of Neurology, 20, 727-731.

McCall, F., & Moodle, E. (1998). Training staff to support AAC users in Scotland: Current status and needs. Augmentative and Alternative Communication, 14(4), 228-238.

Middleton, F. A., & Strick, P. L. (2000). Basal ganglia output and cognition: Evidence from anatomical, behavorial, and clinical studies. Brain and Cognition, 42(2), 183-200.

Minden, S. L., & Schiffer, R. B. (1990). Affective disorders in multiple sclerosis: Review and recommendations for clinical research. Archives of Neurology, 47, 98-104.

Mirenda, P. (1985). Designing pictorial communication systems for physically able-bodied students with severe handicaps. Augmentative and Alternative Communication, 1, 58-64.

Munchau, A., & Bhatia, K. P. (2000). Pharmacological treatment of Parkinson's disease. Postgraduate Medical Journal, 76, 602-610.

Murray, L. L., Ramage, A. E., & Hopper, T. (2001). Memory impairments in adults with neurogenic communication disorders. Seminars in Speech and Language, 22(2), 127-137.

National MS Society. (2001). National MS Society Disease Management Consensus Statement. Retrieved 10/18, 2001, from

Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000). Multiple sclerosis. New England Journal of Medicine, 343(13), 938-952.

Oliver, J., & Dewhurst, K. (1969). Childhood and adolescent forms of Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 32(5), 455-459.

Olmas-Lau, N., Ginsberg, M., & Geller, G. (1977). Aphasia in multiple sclerosis. Neurology, 27, 623-626.

Pepping, M., & Ehde, D. M. (2005). Neuropsychological evaluation and treatment of multiple sclerosis: The importance of a neuro-rehabilitation focus. Physical Medicine & Rehabilitation Clinics of North America, 16, 411-436.

Poewe, W. H., & Wenning, G. K. (1998). The natural history of Parkinson's disease. Annual of Neurology, 44(3 Suppl 1), S1-9.

Porter, P. B. (1989). Intervention in end stage of multiple sclerosis: A case study. Augmentative and Alternative Communication, 5(2), 125-127.

Ramig, L. O., Fox, C., & Sapir, S. (2004). Parkinson's disease: Speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Seminars in Speech and Language, 25(2), 169-180.

Schoenfeld, M., Myers, R. H., Cupples, L. A., Berkman, D., Sax, D. S., & Clark, E. (1984). Increased rate of suicide among patients with Huntington's disease. Journal of Neuology, Neurosurgery, and Psychiatry, 47, 1283-1287.

Slaughter, J. R., Slaughter, K. A., Nichols, D., Holmes, S. E., & Martens, M. P. (2001). Prevalence, clinical manifiestations, etiology, and treatment of depression in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neuroscience, 13, 187-196.

Spencer, K. A., Yorkston, K. M., & Duffy, J. R. (2003). Behavioral management of respiratory/phonatory dysfunction from dysarthria: A flowchart for guidance in clinical decision-making. Journal of Medical Speech-Language Pathology, 11(2), xxxix-lxi.

Stewart, C., Winfield, L., Hunt, A., Bressman, S. B., Fahn, S., Blitzer, A., et al. (1995). Speech dysfunction in early Parkinson's disease. Movement Disorders, 10(5), 562-565.

Stewart, F., Worrall, L., Egan, J., & Oxenham, D. (2004). Addressing internet training issues for people with Parkinson's disease. Advances in Speech Language Pathology, 6(4), 209-220.

Stocchi, F., & Brusa, L. (2000). Cognition and emotion in different stages and subtypes of Parkinson's disease. Journal of Neurology, 247(Supple 2), II/114-II/121.

Sullivan, F. R., Bird, E. D., Alpay, M., & Cha, J. J. (2001). Remotivation therapy and Huntington's disease. Journal of Neuroscience Nursing, 33(3), 136-142.

Trinka, E., Unterberger, I., Luef, G., Benke, T., & Berger, T. (2001). Acute aphasia in multiple sclerosis. Archives of Neurology, 58(133-134).

Turkstra, L. S. (2001). Treating memory problems in adults with neurogenic communication disorders. Seminars in Speech and Language, 22(2), 147-155.

Webb, M., & Trzepacz, P. T. (1987). Hungtington's disease: Correlations of mental status with chorea. Biological Psychiatry, 22, 751-761.

Weinstock-Guttman, B., & Jacobs, L. D. (2000). What is new in the treatment of multiple sclerosis? Drugs, 59(3), 401-410.

Yorkston, K. M., Beukelman, D. R., Strand, E. A., & Bell, K. R. (1999). Management of motor speech disorders in children and adults (2nd ed.). Austin, TX: Pro-Ed.

Yorkston, K. M., Klasner, E. R., Bowen, J., Ehde, D. M., Gibbons, L., Johnson, K., et al. (2003). Characteristics of multiple sclerosis as a function of the severity of speech disorders. Journal of Medical Speech-Language Pathology, 11(2), 73-85.

Yorkston, K. M., Klasner, E. R., & Swanson, K. M. (2001). Communication in context: A qualitative study of the experiences of individuals with multiple sclerosis. American Journal of Speech-Language Pathology, 10(2), 126-137.

Yorkston, K. M., Miller, R. M., & Strand, E. A. (2004). Management of Speech and Swallowing Disorders in Degenerative Disease. (2nd ed.). Austin, TX: Pro-Ed.

Yorkston, K. M., Spencer, K. A., & Duffy, J. R. (2003). Behavioral management of respiratory/phonatory dysfunction from dysarthria: A systematic review of the evidence. Journal of Medical Speech-Language Pathology, 11(2), xiii-xxxviii.

Zakzanis, K. K. (2000). Distinct neurocognitive profiles in multiple sclerosis subtype. Archives of Clinical Neuropsychology, 15(2), 115-136.

Zetusky, W. J., Jankovic, J., & Pirozzolo, F. J. (1985). The heterogeneity of Parkinson's disease: Clinical and prognostic implications. Neurology, 35, 522-526.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download